45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
6,435
Insurances with rates
12
CPT / HCPCS codes
1
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 2209529 | INJECTION, IPILIMUMAB, 1 MG | $58,073 | $58,073 | — | — | 12 |
| 2200032 | INJECTION, RAVULIZUMAB-CWVZ, 10 MG | $50,438 | $50,438 | — | — | 12 |
| 2200092 | INJECTION, OCRELIZUMAB, 1 MG | $34,905 | $34,905 | — | — | 12 |
| 2200085 | INJECTION, LUSPATERCEPT-AAMT, 0.25 MG | $22,175 | $22,175 | — | — | 12 |
| 2200550 | USTEKINUMAB, FOR SUBCUTANEOUS INJECTION, 1 MG | $22,108 | $22,108 | — | — | 12 |
| 2200031 | INJECTION, ATEZOLIZUMAB, 10 MG | $21,156 | $21,156 | — | — | 12 |
| 2208488 | INJECTION, DARATUMUMAB, 10 MG AND HYALURONIDASE-FIHJ | $17,972 | $17,972 | — | — | 12 |
| 2209528 | INJECTION, IPILIMUMAB, 1 MG | $17,698 | $17,698 | — | — | 12 |
| 2209510 | INJECTION, NATALIZUMAB, 1 MG | $17,302 | $17,302 | — | — | 12 |
| 2200124 | INJECTION, VEDOLIZUMAB, INTRAVENOUS, 1 MG | $16,996 | $16,996 | — | — | 12 |
| 2208956 | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG | $16,358 | $16,358 | — | — | 12 |
| 2200014 | INJECTION, NIVOLUMAB, 1 MG | $15,578 | $15,578 | — | — | 12 |
| 2207271 | INJECTION, TENECTEPLASE, 1 MG | $15,309 | $15,309 | — | — | 12 |
| 2207670 | INJECTION, PEGFILGRASTIM, EXCLUDES BIOSIMILAR, 0.5 MG | $14,213 | $14,213 | — | — | 12 |
| 2209502 | INJECTION, PEGFILGRASTIM, EXCLUDES BIOSIMILAR, 0.5 MG | $14,213 | $14,213 | — | — | 12 |
| 2200033 | INJECTION, RAVULIZUMAB-CWVZ, 10 MG | $14,183 | $14,183 | — | — | 12 |
| 2200076 | INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG | $14,145 | $14,145 | — | — | 12 |
| 6200992 | STRATTICE 10 x 20 cm LIFECELL TISSUE | $13,463 | $13,463 | — | — | 12 |
| 2207884 | INJECTION, PANITUMUMAB, 10 MG | $13,161 | $13,161 | — | — | 12 |
| 2204081 | INJECTION, PERTUZUMAB, 1 MG | $13,089 | $13,089 | — | — | 12 |
| 2200018 | INJECTION, OFATUMUMAB, 10 MG | $13,010 | $13,010 | — | — | 12 |
| 2200047 | INJECTION, ATEZOLIZUMAB, 10 MG | $12,768 | $12,768 | — | — | 12 |
| 2200074 | INJECTION, ADO-TRASTUZUMAB EMTANSINE, 1 MG | $12,503 | $12,503 | — | — | 12 |
| 2209533 | INJECTION, GOLIMUMAB, 1 MG, FOR INTRAVENOUS USE | $12,396 | $12,396 | — | — | 12 |
| 2208946 | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG | $12,375 | $12,375 | — | — | 12 |
| 2209551 | INJECTION, BENRALIZUMAB, 1 MG | $11,921 | $11,921 | — | — | 12 |
| 6210030 | MESH PHASIX ST 8X10 | $11,804 | $11,804 | — | — | 12 |
| 2200013 | INJECTION, PEMBROLIZUMAB, 1 MG | $11,677 | $11,677 | — | — | 12 |
| 2209351 | INJECTION, CERTOLIZUMAB PEGOL, 1 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE | $11,382 | $11,382 | — | — | 12 |
| 2200164 | INJECTION, RASBURICASE, 0.5 MG | $11,303 | $11,303 | — | — | 12 |
| 2208917 | INJECTION, RITUXIMAB, 10 MG | $10,518 | $10,518 | — | — | 12 |
| 2209543 | INJECTION, ROMIPLOSTIM, 10 MICROGRAMS | $10,103 | $10,103 | — | — | 12 |
| 6200299 | HIP PROSTHESIS | $9,670 | $9,670 | — | — | 12 |
| 2206839 | INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG | $9,588 | $9,588 | — | — | 12 |
| 2200023 | INJECTION, PEGFILGRASTIM-CBQV (UDENYCA), BIOSIMILAR, 0.5 MG | $9,395 | $9,395 | — | — | 12 |
| 2207671 | INJECTION, PEGFILGRASTIM-JMDB (FULPHILA), BIOSIMILAR, 0.5 MG | $9,395 | $9,395 | — | — | 12 |
| 2209376 | INJECTION, PEMETREXED, NOT OTHERWISE SPECIFIED, 10 MG | $9,112 | $9,112 | — | — | 12 |
| 2208797 | INJECTION, ADALIMUMAB, 20 MG | $9,033 | $9,033 | — | — | 12 |
| 2200953 | INJECTION, DARBEPOETIN ALFA, 1 MICROGRAM (NON-ESRD USE) | $8,740 | $8,740 | — | — | 12 |
| 2200063 | INJECTION, LUSPATERCEPT-AAMT, 0.25 MG | $8,273 | $8,273 | — | — | 12 |
| 2208976 | INJECTION, IMMUNE GLOBULIN, (OCTAGAM), INTRAVENOUS, NON-LYOPHILIZED (E.G., LIQUID), 500 MG | $8,143 | $8,143 | — | — | 12 |
| 1505010 | Shock wave crushing of kidney stones | $8,127 | $8,127 | — | — | 12 |
| 2203401 | INJECTION, RITUXIMAB-PVVR, BIOSIMILAR, (RUXIENCE), 10 MG | $8,126 | $8,126 | — | — | 12 |
| 2200075 | INJECTION, ADO-TRASTUZUMAB EMTANSINE, 1 MG | $7,975 | $7,975 | — | — | 12 |
| 5410106 | DRSG DERMAL REGENERATION 4X10 | $7,513 | $7,513 | — | — | 12 |
| 2209540 | UNCLASSIFIED BIOLOGICS | $7,494 | $7,494 | — | — | 12 |
| 2200079 | INJECTION, MEPOLIZUMAB, 1 MG | $7,436 | $7,436 | — | — | 12 |
| 2208970 | INJECTION, IMMUNE GLOBULIN (PRIVIGEN), INTRAVENOUS, NON-LYOPHILIZED (E.G., LIQUID), 500 MG | $7,412 | $7,412 | — | — | 12 |
| 2200194 | UNCLASSIFIED DRUGS | $7,409 | $7,409 | — | — | 12 |
| 2209461 | INJECTION, ZIV-AFLIBERCEPT, 1 MG | $7,301 | $7,301 | — | — | 12 |
Showing top 50 of 6,435 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.